article · Neurology

Efficacy and safety of different doses of subcutaneous galcanezumab in chronic and episodic migraine: A pooled analysis of 3651 patients (P10-12.003)

Mohamed Sayed Zaazouee
Mohamed Elshennawy
Ziad Alahmad
Ahmed Bostamy Elsnhory
Ahmed S. Saad
Ghaida’a Al-araj
Omar Khaled Fahmy Fawy
Ibram Zaki
Mohammed Eleyan
Rokaya Y. Ebrahim
Hadi F. Ahmed
Reem I. Abo Hamra
Mustafa Hussein Ali
Rasha Abdo Elromely
Hazem AbuEl-Enien
Alaa Ahmed Elshanbary

2023Pharos University in Alexandria

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

In this systematic review and meta-analysis, we aimed to assess the efficacy and safety of galcanezumab doses in chronic and episodic migraines.

Research topics

Migraine and Headache Studies

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1212/wnl.0000000000203515

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.